What is LOPJLB’s current signal on ASMB?

LOPJLB’s latest quantitative signal on Assembly Biosciences, Inc. (ASMB) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ASMB in?

Assembly Biosciences, Inc. (ASMB) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Assembly Biosciences, Inc. (ASMB) do?

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate, Vebicorvir, has successfully concluded Phase 2 clinical trials for individuals with chronic HBV. The company's development pipeline also features …

Where is Assembly Biosciences, Inc. based / listed?

Assembly Biosciences, Inc. is based in US, listed on NASDAQ.

Assembly Biosciences, Inc. (ASMB)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$23.53+3.11%Close

SELLCRISIS · day 22

[SCORES & PROFILE]

FUND: 8
VALUE: 1
GROWTH: 37
GARP: 7
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-0.0%

REV YoY-

ROE-0.0%

EPS YoY-

ROA-0.0%

GROSS

-12

NET

[VALUATION]

P/E TTM40.33

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B1.37

P/FCF-

EV/EBITDA6023.68

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E0.77

ALTMAN Z-

CURR RATIO13.99

ND/EBITDA-

BETA1.13

Assembly Biosciences, Inc. (ASMB)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news